{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:02:13Z","timestamp":1791396133719,"version":"4.3.3"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,7]]},"DOI":"10.1093\/cid\/ciag423","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:00:08Z","timestamp":1783598408000},"page":"e537-e538","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of Hepatitis C During Pregnancy: We Are Approaching a \u201cTipping Point\u201d"],"prefix":"10.1093","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9921-0419","authenticated-orcid":false,"given":"Ravi","family":"Jhaveri","sequence":"first","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine , Chicago, Illinois ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"2026100713432386900_ciag423-B1","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","article-title":"Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection","volume":"373","author":"Feld","year":"2015","journal-title":"N Engl J Med"},{"key":"2026100713432386900_ciag423-B2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jhep.2017.03.039","article-title":"Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1\u20136 without cirrhosis","volume":"67","author":"Kwo","year":"2017","journal-title":"J Hepatol"},{"key":"2026100713432386900_ciag423-B3","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/hep.31825","article-title":"Responsible inclusion of pregnant individuals in eradicating HCV","volume":"74","author":"Jhaveri","year":"2021","journal-title":"Hepatology"},{"key":"2026100713432386900_ciag423-B4","author":"American Association for the Study of Liver Diseases\/Infectious Diseases Society of America","year":"2023"},{"key":"2026100713432386900_ciag423-B5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/AOG.0000000000005300","article-title":"Viral hepatitis in pregnancy: ACOG clinical practice guideline no. 6","volume":"142","year":"2023","journal-title":"Obstet Gynecol"},{"key":"2026100713432386900_ciag423-B6","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/cid\/ciae595","article-title":"Sofosbuvir\/velpatasvir pharmacokinetics, safety, and efficacy in pregnant people with hepatitis C virus","volume":"80","author":"Chappell","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026100713432386900_ciag423-B7","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1053\/j.gastro.2022.07.017","article-title":"Treatment of women with hepatitis C diagnosed in pregnancy: a co-located treatment approach","volume":"163","author":"Kushner","year":"2022","journal-title":"Gastroenterology"},{"key":"2026100713432386900_ciag423-B8","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13102462","article-title":"Pharmacokinetics of sofosbuvir and velpatasvir for hepatitis C treatment in pregnancy","volume":"13","author":"Giles","year":"2025","journal-title":"Biomedicines"},{"key":"2026100713432386900_ciag423-B9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11904-018-0386-z","article-title":"Treatment of hepatitis C during pregnancy-weighing the risks and benefits in contrast to HIV","volume":"15","author":"Barritt","year":"2018","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2026100713432386900_ciag423-B10","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S2666-5247(20)30062-8","article-title":"Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study","volume":"1","author":"Chappell","year":"2020","journal-title":"Lancet Microbe"},{"key":"2026100713432386900_ciag423-B11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ajog.2024.06.028","article-title":"Best practices for hepatitis C linkage to care in pregnant and postpartum women: perspectives from the Treatment In Pregnancy for Hepatitis C Community of Practice","volume":"231","author":"Gupta","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"2026100713432386900_ciag423-B12","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciag422","article-title":"Real-world experience of hepatitis C treatment with glecaprevir\/pibrentasvir during pregnancy","author":"McCrary","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026100713432386900_ciag423-B13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/v18020269","article-title":"Predictive value of sustained virologic response at week 4 in patients with hepatitis C virus infection treated with sofosbuvir\/velpatasvir","volume":"18","author":"Landry","year":"2026","journal-title":"Viruses"},{"key":"2026100713432386900_ciag423-B14","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000004014","article-title":"Temporal trends in hepatitis C virus screening and management in pregnant women and infants between 2014 and 2024 in San Francisco, California [manuscript published online ahead of print 31 March 2026]","author":"Betancourt","year":"2026","journal-title":"Am J Gastroenterol"},{"key":"2026100713432386900_ciag423-B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults\u2014United States, 2020","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"2026100713432386900_ciag423-B16","first-page":"974","article-title":"Point-of-care testing for hepatitis C infection: a critical building block for the foundation to achieve elimination","volume":"79","author":"Grebely","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026100713432386900_ciag423-B17","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/cid\/ciad503","article-title":"The urgent need to implement point-of-care RNA testing for hepatitis C virus to support elimination","volume":"78","author":"Kapadia","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026100713432386900_ciag423-B18","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1093\/cid\/ciaa571","article-title":"Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: the ETHOS engage study","volume":"73","author":"Valerio","year":"2021","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciag423\/70479000\/ciag423.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/83\/3\/e537\/70479000\/ciag423.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/83\/3\/e537\/70479000\/ciag423.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:43:31Z","timestamp":1791395011000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/83\/3\/e537\/8750981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,8,11]]},"published-print":{"date-parts":[[2026,10,7]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag423","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9,15]]},"published":{"date-parts":[[2026,8,11]]}}}